|
1
|
Chang ET and Adami HO: The enigmatic
epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol
Biomarkers Prev. 15:1765–1777. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wei KR, Zheng RS, Zhang SW, Liang ZH, Ou
ZX and Chen WQ: Nasopharyngeal carcinoma incidence and mortality in
China in 2010. Chin J Cancer. 33:381–387. 2014.PubMed/NCBI
|
|
3
|
Xu T, Tang J, Gu M, Liu L, Wei W and Yang
H: Recurrent nasopharyngeal carcinoma: A clinical dilemma and
challenge. Curr Oncol. 20:e406–e419. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang C: Radiation Therapy for Head and
Neck Neoplasms. 3rd. Wiley-Liss; New York, NY: 1997
|
|
5
|
Zhang Z, Filho MS and Nör JE: The biology
of head and neck cancer stem cells. Oral Oncol. 48:1–9. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Clarke MF, Dick JE, Dirks PB, Eaves CJ,
Jamieson CH, Jones DL, Visvader J, Weissman IL and Wahl GM: Cancer
stem cells-perspectives on current status and future directions:
AACR Workshop on cancer stem cells. Cancer Res. 66:9339–9344. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ke J, Wu X, Wu X, He X, Lian L, Zou Y, He
X, Wang H, Luo Y, Wang L and Lan P: A subpopulation of
CD24+ cells in colon cancer cell lines possess stem cell
characteristics. Neoplasma. 59:282–288. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jaggupilli A and Elkord E: Significance of
CD44 and CD24 as cancer stem cell markers: An enduring ambiguity.
Clin Dev Immunol. 2012:7080362012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ricardo S, Vieira AF, Gerhard R, Leitão D,
Pinto R, Cameselle-Teijeiro JF, Milanezi F, Schmitt F and Paredes
J: Breast cancer stem cell markers CD44, CD24 and ALDH1: Expression
distribution within intrinsic molecular subtype. J Clin Pathol.
64:937–946. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Q, Chen ZG, Du CZ, Wang HW, Yan L and
Gu J: Cancer stem cell marker CD133+ tumour cells and clinical
outcome in rectal cancer. Histopathology. 55:284–293. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kondo T, Setoguchi T and Taga T:
Persistence of a small subpopulation of cancer stem-like cells in
the C6 glioma cell line. Proc Natl Acad Sci USA. 101:781–786. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Haraguchi N, Utsunomiya T, Inoue H, Tanaka
F, Mimori K, Barnard GF and Mori M: Characterization of a side
population of cancer cells from human gastrointestinal system. Stem
Cells. 24:506–513. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Deng CC, Liang Y, Wu MS, Feng FT, Hu WR,
Chen LZ, Feng QS, Bei JX and Zeng YX: Nigericin selectively targets
cancer stem cells in nasopharyngeal carcinoma. Int J Biochem Cell
Biol. 45:1997–2006. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu MS, Wang GF, Zhao ZQ, Liang Y, Wang HB,
Wu MY, Min P, Chen LZ, Feng QS, Bei JX, et al: Smac mimetics in
combination with TRAIL selectively target cancer stem cells in
nasopharyngeal carcinoma. Mol Cancer Ther. 12:1728–1737. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zou QF, Du JK, Zhang H, Wang HB, Hu ZD,
Chen SP, Du Y, Li MZ, Xie D, Zou J, et al: Anti-tumour activity of
longikaurin A (LK-A), a novel natural diterpenoid, in
nasopharyngeal carcinoma. J Transl Med. 11:2002013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liao YJ, Bai HY, Li ZH, Zou J, Chen JW,
Zheng F, Zhang JX, Mai SJ, Zeng MS, Sun HD, et al: Longikaurin A, a
natural ent-kaurane, induces G2/M phase arrest via downregulation
of Skp2 and apoptosis induction through ROS/JNK/c-Jun pathway in
hepatocellular carcinoma cells. Cell Death Dis. 5:e11372014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jin ZJ: About the evaluation of drug
combination. Acta Pharmacol Sin. 25:146–147. 2004.PubMed/NCBI
|
|
18
|
Cao JY, Liu L, Chen SP, Zhang X, Mi YJ,
Liu ZG, Li MZ, Zhang H, Qian CN, Shao JY, et al: Prognostic
significance and therapeutic implications of centromere protein F
expression in human nasopharyngeal carcinoma. Mol Cancer.
9:2372010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang J, Guo LP, Chen LZ, Zeng YX and Lu
SH: Identification of cancer stem cell-like side population cells
in human nasopharyngeal carcinoma cell line. Cancer Res.
67:3716–3724. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guo Y, Zhu XD, Qu S, Li L, Su F, Li Y,
Huang ST and Li DR: Identification of genes involved in
radioresistance of nasopharyngeal carcinoma by integrating gene
ontology and protein-protein interaction networks. Int J Oncol.
40:85–92. 2012.PubMed/NCBI
|
|
21
|
Ou J, Pan F, Geng P, Wei X, Xie G, Deng J,
Pang X and Liang H: Silencing fibronectin extra domain A enhances
radiosensitivity in nasopharyngeal carcinomas involving an
FAK/Akt/JNK pathway. Int J Radiat Oncol Biol Phys. 82:e685–e691.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wei P, Niu M, Pan S, Zhou Y, Shuai C, Wang
J, Peng S and Li G: Cancer stem-like cell: A novel target for
nasopharyngeal carcinoma therapy. Stem Cell Res Ther. 5:1–9. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nair R, Roden DL, Teo WS, McFarland A,
Junankar S, Ye S, Nguyen A, Yang J, Nikolic I, Hui M, et al: c-Myc
and Her2 cooperate to drive a stem-like phenotype with poor
prognosis in breast cancer. Oncogene. 33:3992–4002. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang WJ, Wu SP, Liu JB, Shi YS, Huang X,
Zhang QB and Yao KT: MYC regulation of CHK1 and CHK2 promotes
radioresistance in a stem cell-like population of nasopharyngeal
carcinoma cells. Cancer Res. 73:1219–1231. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ou JJ, Wu F and Liang HJ: Colorectal tumor
derived fibronectin alternatively spliced EDA domain exserts
lymphangiogenic effect on human lymphatic endothelial cells. Cancer
Biol Ther. 9:186–191. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu T, Tang J, Gu M, Liu L, Wei W and Yang
H: Recurrent nasopharyngeal carcinoma: A clinical dilemma and
challenge. Curr Oncol. 20:e406–e419. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao S, Pu JX, Sun HD and Wu YL:
Longikaurin A induces apoptosis of multiple myeloma H929 cells.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 20:611–615. 2012.(In Chinese).
PubMed/NCBI
|
|
28
|
French-Constant C: Alternative splicing of
fibronectin-many different proteins but few different functions.
Exp Cell Res. 221:261–271. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xie XY, Liu SL, Wang H, Lin L, Zhu HM,
Zhang JJ and Zheng Y: The influence of fibronectin on the formation
of multi-cellular spheroid of ovarian cancer. Sichuan Da Xue Xue
Bao Yi Xue Ban. 45:240–244. 2014.(In Chinese). PubMed/NCBI
|
|
30
|
Wang J, Huang Y, Guan Z, Zhang JL, Su HK,
Zhang W, Yue CF, Yan M, Guan S and Liu QQ: E3-ligase Skp2 predicts
poor prognosis and maintains cancer stem cell pool in
nasopharyngeal carcinoma. Oncotarget. 5:5591–5601. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
O'Donnell KA, Wentzel EA, Zeller KI, Dang
CV and Mendell JT: c-Myc-regulated microRNAs modulate E2F1
expression. Nature. 435:839–843. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zheng H, Ying H, Yan H, Kimmelman AC,
Hiller DJ, Chen AJ, Perry SR, Tonon G, Chu GC, Ding Z, et al: Pten
and p53 converge on c-Myc to control differentiation, self-renewal
and transformation of normal and neoplastic stem cells in
glioblastoma. Cold Spring Harb Symp Quant Biol. 73:427–437. 2008.
View Article : Google Scholar : PubMed/NCBI
|
